CRi's Multispectral Imaging System recognized as a 'Top 10 Medical Innovation for 2009'

Cambridge Research & Instrumentation, Inc. (CRi) announced today that the technology of multispectral imaging was ranked as a Top Ten Medical Innovation at Cleveland Clinic’s 6th Annual Medical Innovations Summit.

During the recognition presentation, Dr. Jennifer Hunt, head of surgical pathology at the Cleveland Clinic stated, “When we’re talking about tumors, we’re talking about what information can we gain about that tumor to guide and direct therapy, prognosis, diagnostics. We believe this technology to be a game changer. It will take personalized medicine to an entirely new level. This is not a step, but a leap. Being able to analyze multiple markers in a single cell to understand the behavior of actual signaling pathways will significantly aid in disease diagnosis and therapy development.” Dr. Hunt went on to add, “I expect that this technology will be rapidly adopted across the field of pathology.”

LOT represent CRi in the UK & Ireland. For more details please click the article webpage link on the right.

The Nuance system offers CRi's patented multispectral imaging capabilities at the subcellular, cellular and tissue level. Nuance systems can be easily added onto existing brightfield and fluorescence microscopes with a simple c-mount connection, and are affordable for research labs.